Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Curry

Showing results (541-550 of 566) with videos related to

Pageof 57
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2018
Ablation of insulin receptor substrates 1 and 2 suppresses <i>Kras</i>-driven lung tumorigenesisHe Xu, Min-Sik Lee, Pei-Yun Tsai, et al.
Cancers|January 1, 2020
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral MelanomaDinesh Pradhan, George Jour, Denái Milton, et al.
Journal of Cutaneous Pathology|September 14, 2017
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patientsMichael T Tetzlaff, Amir A Jazaeri, Carlos A Torres-Cabala, et al.
Journal of Cutaneous Pathology|March 19, 2019
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14<sup>+</sup> and CD16<sup>+</sup> monocytes driving an innate immune responseJonathan L Curry, Alexandre Reuben, Robert Szczepaniak-Sloane, et al.
The Journal of Pathology|June 12, 2016
Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinomaMichael T Tetzlaff, Rajesh R Singh, Elena G Seviour, et al.
Journal of Cutaneous Pathology|March 11, 2015
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutationsDavid L Stockman, Jonathan L Curry, Carlos A Torres-Cabala, et al.
Journal of Cutaneous Pathology|January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotinWoo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Cancer Cell|June 15, 2016
ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in CancerMarco Napoli, Avinashnarayan Venkatanarayan, Payal Raulji, et al.
Human Pathology|June 11, 2015
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced MelanomaMichael T Tetzlaff, Penvadee Pattanaprichakul, Jennifer Wargo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular DensityPhyu P Aung, Edwin Roger Parra, Souptik Barua, et al.
Pageof 57

Showing results (541-550 of 566) with videos related to

Sort By:
Pageof 57
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2018
Ablation of insulin receptor substrates 1 and 2 suppresses <i>Kras</i>-driven lung tumorigenesisHe Xu, Min-Sik Lee, Pei-Yun Tsai, et al.
Cancers|January 1, 2020
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral MelanomaDinesh Pradhan, George Jour, Denái Milton, et al.
Journal of Cutaneous Pathology|September 14, 2017
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patientsMichael T Tetzlaff, Amir A Jazaeri, Carlos A Torres-Cabala, et al.
Journal of Cutaneous Pathology|March 19, 2019
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14<sup>+</sup> and CD16<sup>+</sup> monocytes driving an innate immune responseJonathan L Curry, Alexandre Reuben, Robert Szczepaniak-Sloane, et al.
The Journal of Pathology|June 12, 2016
Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinomaMichael T Tetzlaff, Rajesh R Singh, Elena G Seviour, et al.
Journal of Cutaneous Pathology|March 11, 2015
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutationsDavid L Stockman, Jonathan L Curry, Carlos A Torres-Cabala, et al.
Journal of Cutaneous Pathology|January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotinWoo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.
Cancer Cell|June 15, 2016
ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in CancerMarco Napoli, Avinashnarayan Venkatanarayan, Payal Raulji, et al.
Human Pathology|June 11, 2015
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced MelanomaMichael T Tetzlaff, Penvadee Pattanaprichakul, Jennifer Wargo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular DensityPhyu P Aung, Edwin Roger Parra, Souptik Barua, et al.
Pageof 57